Federal contract award
70US0923F3OTH2440
DRUG TESTING SERVICES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Homeland Security |
| Office | U. S. SECRET SERVICE |
| NAICS | 621999 — All Other Miscellaneous Ambulatory Health Care Services |
| PSC | Q999 — Other Medical Services |
| Parent award / vehicle | 140D0423D0045 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $618.9K |
| Current contract value | $618.9K |
| Potential contract value / ceiling | $716.2K |
| Start date | Apr 13, 2023 |
| Current end date | Apr 13, 2027 |
| Potential end date | Apr 13, 2028 |
| Latest award activity | Jun 22, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 22, 2026 | P00007 | $225.9K | THIS MODIFICATION IS TO FULLY FUND OPTION YEAR 3 (CLIN 3001) IN THE AMOUNT OF $225,863.61 FOR DRUG TESTING LABORATORY SERVICES. |
| Apr 20, 2026 | P00006 | $0 | 1. EXERCISE OPTION YEAR 3 (CLIN 3001) FOR DRUG TESTING SERVICES SUBJECT TO THE AVAILABILITY OF FUNDS. THE PERIOD OF PERFORMANCE IS APRIL 14, 2026, TO APRIL 13, 2027. 2. INCORPORATE CLAUSE FAR 52.232-18, AVAILABILITY OF FUNDS (APR 1984) |
| Feb 4, 2026 | P00005 | $37.9K | THIS MODIFICATION IS TO ADD FUNDING TO OPTION YEAR 2 CLIN 2001 IN THE AMOUNT OF $37,858.00 FOR DRUG TESTING SERVICES. PSC CODE-Q999. |
| Sep 9, 2025 | P00003 | $64.7K | THIS MODIFICATION IS TO ADD FUNDING TO CLIN 2001 IN THE AMOUNT OF $64,684.00 FOR DRUG TESTING SERVICES. PSC CODE-Q999. |
| Apr 14, 2025 | P00002 | $97.3K | PER EO 14222 EXCEPTION 4(A): THIS MODIFICATION IS TO EXERCISE OPTION YEAR 2 FOR DRUG TESTING SERVICES PER CLIN 2001 FOR $97,303.51. PSC CODE-Q999. |
| Apr 1, 2024 | P00001 | $96.8K | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION YEAR 1 ON THE CONTRACT. |
| Apr 14, 2023 | 0 | $96.4K | DRUG TESTING SERVICES |
Estimated positioning window
Apr 13, 2027 – Oct 13, 2027
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2028-04-13 (529 days from calculation)
- +25 points
- 3 historical awards in this buyer and category group
- +10 points
- 7 recorded award transactions
- +10 points
- Latest award action: 2026-06-22
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.